Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Medicaid topic
No spam. Unsubscribe anytime.
Committee advances bill that would let LDH cover FDA‑approved weight‑loss drugs subject to appropriation
Summary
Senate Bill 433 would require LDH to provide Medicaid coverage for FDA‑approved weight‑loss medications judged medically necessary, but the department said the expansion is now subject to appropriation and departmental criteria; LDH estimates around $240 million currently spent on GLP‑1s under existing narrower coverage.
Senate Bill 433, carried to the committee by Secretary Greenstein’s office, would direct the Louisiana Department of Health to provide Medicaid coverage for medically necessary, FDA‑approved weight‑loss medications — including GLP‑1 class drugs — and to establish coverage criteria. LDH Medicaid director Seth Gold explained the bill is aimed at expanding coverage beyond current criteria tied to obesity with certain comorbidities (diabetes, sleep apnea, congestive heart failure and other conditions) and said the department currently spends roughly $240 million on GLP‑1 coverage at preferred pricing.
Gold told the committee the bill was amended in committee to make coverage subject to legislative appropriation and to give LDH discretion to craft fiscally sustainable eligibility criteria aligned to available funding. That change, he said, flipped the department’s initial modeling: rather than an unfunded expansion set in statute, the department would implement coverage consistent with appropriations and department rulemaking.
Members asked several fiscal questions. Representative Barrow and others pressed about coordination with Appropriations; LDH said the expanded benefit is not funded in the current budget and that the department will implement a criterion‑based approach contingent on funding decisions. Several members expressed support for the policy and for moving the bill forward; Representative Barrault moved to report SB 433 favorably, and with no objections the committee reported the bill favorably.
Sen. Greenstein (presenting for the sponsor) and Seth Gold emphasized LDH’s willingness to enact responsible coverage criteria tied to legislative funding decisions. The committee did not adopt a roll‑call vote in committee; the bill was reported favorably with amendments clarifying the subject‑to‑appropriation language and delegating detailed eligibility and utilization controls to LDH rulemaking.
